| Rivastigmine for dementia associated with Parkinson's disease M Emre, D Aarsland, A Albanese, EJ Byrne, G Deuschl, PP De Deyn, ... New England Journal of Medicine 351 (24), 2509-2518, 2004 | 1601 | 2004 |
| Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial VJJ Odekerken, T van Laar, MJ Staal, A Mosch, CFE Hoffmann, ... The Lancet Neurology 12 (1), 37-44, 2013 | 798 | 2013 |
| Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries FPT Hamers, AJ Lankhorst, TJ van Laar, WB Veldhuis, WH Gispen Journal of neurotrauma 18 (2), 187-201, 2001 | 586 | 2001 |
| Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study HMM Smeding, JD Speelman, M Koning-Haanstra, PR Schuurman, ... Neurology 66 (12), 1830-1836, 2006 | 329 | 2006 |
| Randomized delayed-start trial of levodopa in Parkinson’s disease CVM Verschuur, SR Suwijn, JA Boel, B Post, BR Bloem, JJ van Hilten, ... New England Journal of Medicine 380 (4), 315-324, 2019 | 274 | 2019 |
| Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled … R Katzenschlager, W Poewe, O Rascol, C Trenkwalder, G Deuschl, ... The Lancet Neurology 17 (9), 749-759, 2018 | 272 | 2018 |
| Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations AM Meppelink, BM De Jong, R Renken, KL Leenders, FW Cornelissen, ... Brain 132 (11), 2980-2993, 2009 | 210 | 2009 |
| Disease progression continues in patients with advanced Parkinson’s disease and effective subthalamic nucleus stimulation R Hilker, AT Portman, J Voges, MJ Staal, L Burghaus, T Van Laar, ... Journal of Neurology, Neurosurgery & Psychiatry 76 (9), 1217-1221, 2005 | 193 | 2005 |
| Levodopa-carbidopa intestinal gel in advanced Parkinson's: final results of the GLORIA registry A Antonini, W Poewe, KR Chaudhuri, R Jech, B Pickut, Z Pirtošek, J Szasz, ... Parkinsonism & related disorders 45, 13-20, 2017 | 189 | 2017 |
| Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease–Clinical practice recommendations C Trenkwalder, KR Chaudhuri, PJG Ruiz, P LeWitt, R Katzenschlager, ... Parkinsonism & related disorders 21 (9), 1023-1030, 2015 | 172 | 2015 |
| Environmental exposure to pesticides and the risk of Parkinson's disease in the Netherlands M Brouwer, A Huss, M van der Mark, PCG Nijssen, WM Mulleners, ... Environment international 107, 100-110, 2017 | 159 | 2017 |
| Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease A Albanese, U Bonuccelli, C Brefel, KR Chaudhuri, C Colosimo, ... Movement disorders: official journal of the Movement Disorder Society 16 (2 …, 2001 | 147 | 2001 |
| Effects of enriched housing on functional recovery after spinal cord contusive injury in the adult rat AJ Lankhorst, MP ter Laak, TJ van Laar, NLU van Meeteren, ... Journal of neurotrauma 18 (2), 203-215, 2001 | 141 | 2001 |
| Retinal layers in Parkinson's disease: a meta-analysis of spectral-domain optical coherence tomography studies A Chrysou, NM Jansonius, T van Laar Parkinsonism & related disorders 64, 40-49, 2019 | 129 | 2019 |
| Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery T Müller, T van Laar, DR Cornblath, P Odin, F Klostermann, FJ Grandas, ... Parkinsonism & related disorders 19 (5), 501-507, 2013 | 117 | 2013 |
| Postoperative gait deterioration after bilateral subthalamic nucleus stimulation in Parkinson's disease BFL van Nuenen, RAJ Esselink, M Munneke, JD Speelman, T van Laar, ... Movement disorders: official journal of the Movement Disorder Society 23 (16 …, 2008 | 110 | 2008 |
| The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease BR Bloem, WJ Marks, AL Silva de Lima, ML Kuijf, T Van Laar, BPF Jacobs, ... BMC neurology 19 (1), 1-10, 2019 | 93 | 2019 |
| Long-term safety of rivastigmine in Parkinson disease dementia: an open-label, randomized study M Emre, W Poewe, PP De Deyn, P Barone, J Kulisevsky, E Pourcher, ... Clinical neuropharmacology 37 (1), 9-16, 2014 | 89 | 2014 |
| FDG PET, dopamine transporter SPECT, and olfaction: combining biomarkers in REM sleep behavior disorder SK Meles, D Vadasz, RJ Renken, E Sittig‐Wiegand, G Mayer, C Depboylu, ... Movement Disorders 32 (10), 1482-1486, 2017 | 84 | 2017 |
| Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson’s disease C Neef, T Van Laar Clinical pharmacokinetics 37, 257-271, 1999 | 83 | 1999 |
